Experts question efficacy of anti-smoking drugs

03/12/2008 | CNNMoney

Anti-smoking drugs such as Pfizer's Chantix and GlaxoSmithKline's Zyban have been approved by the FDA, but concerns remain over their efficacy and safety. A smoking-cessation expert cautioned smokers against having "false expectations" about the treatments, saying that they only suppress withdrawal, but do not actually address the psychological aspect of nicotine addiction.

View Full Article in:

CNNMoney

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT